Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001933414-26-000118 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 12, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,510
Total Value
$93,505.30
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Aug 10, 2026 | Exercise/Conversion | 2,170 | $16.00 | $34,720.00 | 53,554 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Aug 10, 2026 | Sale | 2,170 | $27.09 | $58,785.30 | 51,384 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Aug 10, 2026 | Exercise/Conversion | 2,170 | $0.00 | $0.00 | 13,024 | Direct | โ | View Details |